Venture Map · Round
Peptomyc — Series A · €11.4M
Announced 2020-12-16 · Barcelona · Biotech / Oncology
Peptomyc is a spin-off of VHIO and ICREA developing Omomyc-based peptide therapies against MYC-driven cancers. It closed an €11.4M equity round led by the Italian fund AurorA Science to take its lead candidate OMO-103 into a Phase I clinical trial. Existing investors Alta Life Sciences and HealthEquity returned, and CDTI Innvierte and business angels joined.
RoundSeries A
Amount€11.4M
LeadAurorA Science
Date2020-12-16
CityBarcelona
SectorBiotech / Oncology
